EyePoint Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 8.33 M | $118.55 M | 0.00% | 11.91% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 6.19 M | $88.18 M | -8.99% | 8.86% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 5.56 M | $79.17 M | -18.24% | 7.95% |
| BLACKROCK, INC. | 11/12/2025 | 4.96 M | $70.69 M | -7.38% | 7.10% |
| FEDERATED HERMES, INC. | 11/03/2025 | 4.42 M | $62.89 M | -3.98% | 6.32% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 4.17 M | $59.41 M | -3.00% | 5.97% |
| VANGUARD GROUP INC | 11/07/2025 | 3.79 M | $54.03 M | -0.21% | 5.43% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 3.57 M | $50.87 M | 0.00% | 5.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 2.14 M | $30.41 M | -8.91% | 3.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.01 M | $28.56 M | 100.00% | 2.87% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.80 M | $25.58 M | 100.00% | 2.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.52 M | $21.71 M | -4.24% | 2.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.51 M | $21.57 M | 18.26% | 2.17% |
| STATE STREET CORP | 11/14/2025 | 1.47 M | $20.98 M | -2.79% | 2.11% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 11/12/2025 | 1.08 M | $15.45 M | -7.27% | 1.55% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 1.05 M | $14.95 M | 0.00% | 1.50% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 1.01 M | $14.41 M | -25.21% | 1.45% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.01 M | $14.39 M | 24.10% | 1.44% |
| MORGAN STANLEY | 11/14/2025 | 978.13 K | $13.93 M | 24.98% | 1.40% |
| ABRDN PLC | 11/07/2025 | 796.80 K | $11.35 M | -22.73% | 1.14% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 756.09 K | $10.77 M | 100.00% | 1.08% |
| HSBC HOLDINGS PLC | 11/13/2025 | 716.45 K | $10.21 M | 13.53% | 1.02% |
| ROSALIND ADVISORS, INC. | 11/13/2025 | 650.00 K | $9.26 M | 100.00% | 0.93% |
| ARTIA GLOBAL PARTNERS LP | 11/14/2025 | 628.37 K | $8.95 M | 98.41% | 0.90% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 531.72 K | $7.57 M | 180.03% | 0.76% |
| NORTHERN TRUST CORP | 11/14/2025 | 504.05 K | $7.18 M | -2.24% | 0.72% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 483.05 K | $6.88 M | 1,166.23% | 0.69% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 367.59 K | $5.23 M | -34.66% | 0.53% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 355.81 K | $5.07 M | -30.52% | 0.51% |
| UBS GROUP AG | 11/13/2025 | 350.16 K | $4.99 M | 177.56% | 0.50% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 347.89 K | $4.95 M | 2.03% | 0.50% |
| MYDA ADVISORS LLC | 11/13/2025 | 300.00 K | $4.27 M | 20.00% | 0.43% |
| INVESCO LTD. | 11/13/2025 | 290.82 K | $4.14 M | 125.84% | 0.42% |
| ROYAL BANK OF CANADA | 11/14/2025 | 258.78 K | $3.69 M | 14.52% | 0.37% |
| BLEICHROEDER LP | 11/14/2025 | 256.52 K | $3.65 M | 0.00% | 0.37% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 247.75 K | $3.48 M | -21.09% | 0.35% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 244.43 K | $3.48 M | 100.00% | 0.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 230.84 K | $3.29 M | 100.00% | 0.33% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 229.09 K | $3.26 M | 227.44% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 215.45 K | $3.07 M | -18.73% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 211.90 K | $3.02 M | 2.02% | 0.30% |
| JANE STREET GROUP, LLC | 11/14/2025 | 210.90 K | $3.00 M | 256.25% | 0.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 201.35 K | $2.87 M | -42.69% | 0.29% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 179.44 K | $2.56 M | -52.38% | 0.26% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 171.67 K | $2.44 M | -0.45% | 0.25% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 140.00 K | $1.99 M | 100.00% | 0.20% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 133.75 K | $1.90 M | 4.05% | 0.19% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 11/14/2025 | 132.76 K | $1.89 M | 0.00% | 0.19% |
| JANE STREET GROUP, LLC | 11/14/2025 | 131.76 K | $1.88 M | 738.19% | 0.19% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 130.12 K | $1.85 M | 38.32% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
EyePoint Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 181 institutional investors and hedge funds held shares of EyePoint Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 8.33 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 6.19 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.56 M
BlackRock, Inc.: 4.96 M
FEDERATED HERMES, INC.: 4.42 M
FRANKLIN RESOURCES INC: 4.17 M
99.20% of EyePoint Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.98 M shares in the last 24 months. This purchase volume represents approximately $1.24 B in transactions.